Should DBS for Psychiatric Disorders Be Considered a Form of Psychosurgery? Ethical and Legal Considerations
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Introduction to Neuroimaging
Introduction to Neuroimaging Janaina Mourao-Miranda • Neuroimaging techniques have changed the way neuroscientists address questions about functional anatomy, especially in relation to behavior and clinical disorders. • Neuroimaging includes the use of various techniques to either directly or indirectly image the structure or function of the brain. • Structural neuroimaging deals with the structure of the brain (e.g. shows contrast between different tissues: cerebrospinal fluid, grey matter, white matter). • Functional neuroimaging is used to indirectly measure brain functions (e.g. neural activity) • Example of Neuroimaging techniques: – Computed Tomography (CT), – Positron Emission Tomography (PET), – Single Photon Emission Computed Tomography (SPECT), – Magnetic Resonance Imaging (MRI), – Functional Magnetic Resonance Imaging (fMRI). • Among other imaging modalities MRI/fMRI became largely used due to its low invasiveness, lack of radiation exposure, and relatively wide availability. • Magnetic Resonance Imaging (MRI) was developed by researchers including Peter Mansfield and Paul Lauterbur, who were awarded the Nobel Prize for Physiology or Medicine in 2003. • MRI uses magnetic fields and radio waves to produce high quality 2D or 3D images of brain structures/functions without use of ionizing radiation (X- rays) or radioactive tracers. • By selecting specific MRI sequence parameters different MR signal can be obtained from different tissue types (structural MRI) or from metabolic changes (functional MRI). MRI/fMRI scanner MRI vs. fMRI -
Current Directions in Social Cognitive Neuroscience Kevin N Ochsner
Current directions in social cognitive neuroscience Kevin N Ochsner Social cognitive neuroscience is an emerging discipline that science (SCN) as a distinct interdisciplinary field that seeks to explain the psychological and neural bases of seeks to understand socioemotional phenomena in terms socioemotional experience and behavior. Although research in of relationships among the social (specifying socioemo- some areas is already well developed (e.g. perception of tionally relevant cues, contexts, experiences, and beha- nonverbal social cues) investigation in other areas has only viors), cognitive (information processing mechanisms), just begun (e.g. social interaction). Current studies are and neural (brain bases) levels of analysis. elucidating; the role of the amygdala in a variety of evaluative and social judgment processes, the role of medial prefrontal Here, I provide a brief synthetic review of selected recent cortex in mental state attribution, how frontally mediated findings organized around types or stages of processing controlled processes can regulate perception and experience, rather than topic domains for the following three reasons. and the way in which these and other systems are recruited First, a process orientation might help to highlight emerg- during social interaction. Future progress will depend upon ing functional principles that cut across topics. Second, the development of programmatic lines of research that SCN encompasses numerous topics, and for many of integrate contemporary social cognitive research with them -
Vascular Factors and Risk for Neuropsychiatric Symptoms in Alzheimer’S Disease: the Cache County Study
International Psychogeriatrics (2008), 20:3, 538–553 C 2008 International Psychogeriatric Association doi:10.1017/S1041610208006704 Printed in the United Kingdom Vascular factors and risk for neuropsychiatric symptoms in Alzheimer’s disease: the Cache County Study .............................................................................................................................................................................................................................................................................. Katherine A. Treiber,1 Constantine G. Lyketsos,2 Chris Corcoran,3 Martin Steinberg,2 Maria Norton,4 Robert C. Green,5 Peter Rabins,2 David M. Stein,1 Kathleen A. Welsh-Bohmer,6 John C. S. Breitner7 and JoAnn T. Tschanz1 1Department of Psychology, Utah State University, Logan, U.S.A. 2Department of Psychiatry, Johns Hopkins Bayview and School of Medicine, Johns Hopkins University, Baltimore, U.S.A. 3Department of Mathematics and Statistics, Utah State University, Logan, U.S.A. 4Department of Family and Human Development, Utah State University, Logan, U.S.A. 5Departments of Neurology and Medicine, Boston University School of Medicine, Boston, U.S.A. 6Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, U.S.A. 7VA Puget Sound Health Care System, and Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, U.S.A. ABSTRACT Objective: To examine, in an exploratory analysis, the association between vascular conditions and the occurrence -
Effect of Dextromethorphan-Quinidine on Agitation in Patients with Alzheimer Disease Dementia a Randomized Clinical Trial
Research Original Investigation Effect of Dextromethorphan-Quinidine on Agitation in Patients With Alzheimer Disease Dementia A Randomized Clinical Trial Jeffrey L. Cummings, MD, ScD; Constantine G. Lyketsos, MD, MHS; Elaine R. Peskind, MD; Anton P. Porsteinsson, MD; Jacobo E. Mintzer, MD, MBA; Douglas W. Scharre, MD; Jose E. De La Gandara, MD; Marc Agronin, MD; Charles S. Davis, PhD; Uyen Nguyen, BS; Paul Shin, MS; Pierre N. Tariot, MD; João Siffert, MD Editorial page 1233 IMPORTANCE Agitation is common among patients with Alzheimer disease; safe, effective Author Video Interview and treatments are lacking. JAMA Report Video at jama.com OBJECTIVE To assess the efficacy, safety, and tolerability of dextromethorphan Supplemental content at hydrobromide–quinidine sulfate for Alzheimer disease–related agitation. jama.com DESIGN, SETTING, AND PARTICIPANTS Phase 2 randomized, multicenter, double-blind, CME Quiz at jamanetworkcme.com and placebo-controlled trial using a sequential parallel comparison design with 2 consecutive CME Questions page 1286 5-week treatment stages conducted August 2012–August 2014. Patients with probable Alzheimer disease, clinically significant agitation (Clinical Global Impressions–Severity agitation score Ն4), and a Mini-Mental State Examination score of 8 to 28 participated at 42 US study sites. Stable dosages of antidepressants, antipsychotics, hypnotics, and antidementia medications were allowed. INTERVENTIONS In stage 1, 220 patients were randomized in a 3:4 ratio to receive dextromethorphan-quinidine (n = 93) or placebo (n = 127). In stage 2, patients receiving dextromethorphan-quinidine continued; those receiving placebo were stratified by response and rerandomized in a 1:1 ratio to dextromethorphan-quinidine (n = 59) or placebo (n = 60). -
Brain Imaging Technologies
Updated July 2019 By Carolyn H. Asbury, Ph.D., Dana Foundation Senior Consultant, and John A. Detre, M.D., Professor of Neurology and Radiology, University of Pennsylvania With appreciation to Ulrich von Andrian, M.D., Ph.D., and Michael L. Dustin, Ph.D., for their expert guidance on cellular and molecular imaging in the initial version; to Dana Grantee Investigators for their contributions to this update, and to Celina Sooksatan for monograph preparation. Cover image by Tamily Weissman; Livet et al., Nature 2017 . Table of Contents Section I: Introduction to Clinical and Research Uses..............................................................................................1 • Imaging’s Evolution Using Early Structural Imaging Techniques: X-ray, Angiography, Computer Assisted Tomography and Ultrasound..............................................2 • Magnetic Resonance Imaging.............................................................................................................4 • Physiological and Molecular Imaging: Positron Emission Tomography and Single Photon Emission Computed Tomography...................6 • Functional MRI.....................................................................................................................................7 • Resting-State Functional Connectivity MRI.........................................................................................8 • Arterial Spin Labeled Perfusion MRI...................................................................................................8 -
Neuroimaging and the Functional Neuroanatomy of Psychotherapy
Psychological Medicine, 2005, 35, 1385–1398. f 2005 Cambridge University Press doi:10.1017/S0033291705005064 Printed in the United Kingdom REVIEW ARTICLE Neuroimaging and the functional neuroanatomy of psychotherapy JOSHUA L. ROFFMAN*, CARL D. MARCI, DEBRA M. GLICK, DARIN D. DOUGHERTY AND SCOTT L. RAUCH Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA ABSTRACT Background. Studies measuring the effects of psychotherapy on brain function are under-rep- resented relative to analogous studies of medications, possibly reflecting historical biases. However, psychological constructs relevant to several modalities of psychotherapy have demonstrable neuro- biological correlates, as indicated by functional neuroimaging studies in healthy subjects. This review examines initial attempts to measure directly the effects of psychotherapy on brain function in patients with depression or anxiety disorders. Method. Fourteen published, peer-reviewed functional neuroimaging investigations of psycho- therapy were identified through a MEDLINE search and critically reviewed. Studies were compared for consistency of findings both within specific diagnostic categories, and between specific mod- alities of psychotherapy. Results were also compared to predicted neural models of psychother- apeutic interventions. Results. Behavioral therapy for anxiety disorders was consistently associated with attenuation of brain-imaging abnormalities in regions linked to the pathophysiology of anxiety, and with acti- vation in regions related to positive reappraisal of anxiogenic stimuli. In studies of major depressive disorder, cognitive behavioral therapy and interpersonal therapy were associated with markedly similar changes in cortical–subcortical circuitry, but in unexpected directions. For any given psy- chiatric disorder, there was only partial overlap between the brain-imaging changes associated with pharmacotherapy and those associated with psychotherapy. -
Glossary of Psychological Terms
Glossary of Psychological Terms From Gerrig, Richard J. & Philip G. Zimbardo. Psychology And Life, 16/e Published by Allyn and Bacon, Boston, MA. Copyright (c) 2002 by Pearson Education. Reprinted by permission of the publisher. http://www.apa.org/research/action/glossary.aspx#b ABCDEFGHIJKLMNOPRSTUVWYZ A A-B-A design Experimental design in which participants first experience the baseline condition (A), then experience the experimental treatment (B), and then return to the baseline (A). Abnormal psychology The area of psychological investigation concerned with understanding the nature of individual pathologies of mind, mood, and behavior. Absolute threshold The minimum amount of physical energy needed to produce a reliable sensory experience; operationally defined as the stimulus level at which a sensory signal is detected half the time. Accommodation The process by which the ciliary muscles change the thickness of the lens of the eye to permit variable focusing on near and distant objects. Accommodation According to Piaget, the process of restructuring or modifying cognitive structures so that new information can fit into them more easily; this process works in tandem with assimilation. Acquisition The stage in a classical conditioning experiment during which the conditioned response is first elicited by the conditioned stimulus. Action potential The nerve impulse activated in a neuron that travels down the axon and causes neurotransmitters to be released into a synapse. Acute stress A transient state of arousal with typically clear onset and offset patterns. Addiction A condition in which the body requires a drug in order to function without physical and psychological reactions to its absence; often the outcome of tolerance and dependence. -
Transcranial Direct Current Stimulation in Psychiatric Disorders
City University of New York (CUNY) CUNY Academic Works Publications and Research City College of New York 2015 Transcranial direct current stimulation in psychiatric disorders Gabriel Tortella University of São Paulo Roberta Casati Università degli Studi Milano Bicocca Luana V M Aparicio University of São Paulo Antonio Mantovani CUNY City College Natasha Senço University of São Paulo See next page for additional authors How does access to this work benefit ou?y Let us know! More information about this work at: https://academicworks.cuny.edu/cc_pubs/658 Discover additional works at: https://academicworks.cuny.edu This work is made publicly available by the City University of New York (CUNY). Contact: [email protected] Authors Gabriel Tortella, Roberta Casati, Luana V M Aparicio, Antonio Mantovani, Natasha Senço, Giordano D'Urso, Jerome Brunelin, Fabiana Guarienti, Priscila Mara Lorencini Selingardi, Débora Muszkat, Bernardo de Sampaio Pereira Junior, Leandro Valiengo, Adriano H. Moffa, Marcel Simis, Lucas Borrione, and Andre R. Brunoni This article is available at CUNY Academic Works: https://academicworks.cuny.edu/cc_pubs/658 World Journal of W J P Psychiatry Submit a Manuscript: http://www.wjgnet.com/esps/ World J Psychiatr 2015 March 22; 5(1): 88-102 Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx ISSN 2220-3206 (online) DOI: 10.5498/wjp.v5.i1.88 © 2015 Baishideng Publishing Group Inc. All rights reserved. REVIEW Transcranial direct current stimulation in psychiatric disorders Gabriel Tortella, Roberta Casati, Luana V M Aparicio, -
How Alpha-Stim® Cranial Electrotherapy Stimulation (CES) Works
How Alpha-Stim® Cranial Electrotherapy Stimulation (CES) Works James Giordano, Ph.D. How does Alpha-Stim cranial electrotherapy stimulation (CES) work? The exact mechanism by which Alpha-Stim produces effects is not fully known. However, based on previous and ongoing studies, it appears that the Alpha-Stim microcurrent waveform activates particular groups of nerve cells that are located at the brainstem, a site at the base of the brain that sits atop of the spinal cord. These groups of nerve cells produce the chemicals serotonin and acetylcholine, which can affect the chemical activity of nerve cells that are both nearby and at more distant sites in the nervous system. In fact, these cells are situated to control the activity of nerve pathways that run up into the brain and that course down into the spinal cord. By changing the electrical and chemical activity of certain nerve cells in the brainstem, Alpha-Stim appears to amplify activity in some neurological systems, and diminish activity in others. This neurological ‘fine tuning’ is called modulation, and occurs either as a result of, or together with the production of a certain type of electrical activity pattern in the brain known as an alpha state which can be measured on brain wave recordings (called electroencephalograms, abbreviated EEG). Such alpha rhythms are accompanied by feelings of calmness, relaxation and increased mental focus. The neurological mechanisms that are occurring during the alpha state appear to decrease stress-effects, reduce agitation and stabilize mood, and control both sensations and perceptions of particular types of pain. These effects can be produced after a single treatment, and repeated treatments have been shown to increase the relative Alpha-Stim CES engages the serotonergic (5-HT) raphe nuclei of the brainstem. -
Functional Imaging in Behavioral Neurology and Cognitive Neuropsychology
Functional Imaging in Behavioral Neurology and Cognitive Neuropsychology Geoffrey Karl Aguirre From: T. E. Feinberg & M. J. Farah (Eds.), Behavioral Neurology and Cognitive Neuropsychology . (in press). New York: McGraw Hill. Introduction What can we hope to learn of the physical operation of the central nervous system and the mental processes that result? The fields of behavioral neurology and cognitive neuropsychology survey this relationship, and have at their disposal powerful intellectual and methodological tools. While the terrain of possible models of brain and behavior interaction seems boundless, particular tests of these models may exist beyond the reach of particular methods. These methods fall into two broad categories, and have been around for several centuries. The first category includes manipulations of the neural substrate itself. Such an intervention might inactivate a brain area, perhaps through a lesion, with Paul Broca’s 1861 observation of the link between language and left frontal lobe damage providing a prototypical example. The effects of stimulation of brain areas can also be studied, as Harvey Cushing did with the human sensory cortex in the early 20th century. In contrast, observation techniques relate a measure of neural function to behavior. Hans Berger’s work in the 1920s on the human electroencephalographic response is a good starting point. Impressive refinements and additions to both of these categories have taken place over the last century. For example, beyond the static lesions of “nature’s accidents” that have been the mainstay of cognitive neuropsychology for many years, it is now possible to temporarily and reversibly inactivate areas of human cortex using transcranial magnetic stimulation (see chapter X for additional details). -
[For Consideration As Part of the ENIGMA Special Issue] Ten Years
[For consideration as part of the ENIGMA Special Issue] Ten years of Enhancing Neuro-Imaging Genetics through Meta-Analysis: An overview from the ENIGMA Genetics Working Group Sarah E. Medland1,2,3, Katrina L. Grasby1, Neda Jahanshad4, Jodie N. Painter1, Lucía Colodro- Conde1,2,5,6, Janita Bralten7,8, Derrek P. Hibar4,9, Penelope A. Lind1,5,3, Fabrizio Pizzagalli4, Sophia I. Thomopoulos4, Jason L. Stein10, Barbara Franke7,8, Nicholas G. Martin11, Paul M. Thompson4 on behalf of the ENIGMA Genetics Working Group 1 Psychiatric Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia. 2 School of Psychology, University of Queensland, Brisbane, Australia. 3 Faculty of Medicine, University of Queensland, Brisbane, Australia. 4 Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine of USC, University of Southern California, Marina del Rey, CA, USA. 5 School of Biomedical Sciences, Queensland University of Technology, Brisbane, Australia. 6 Faculty of Psychology, University of Murcia, Murcia, Spain. 7 Department of Human Genetics, Radboud university medical center, Nijmegen, The Netherlands. 8 Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, The Netherlands. 9 Personalized Healthcare, Genentech, Inc., South San Francisco, USA. 10 Department of Genetics & UNC Neuroscience Center, University of North Carolina at Chapel Hill, Chapel Hill, USA. 11 Genetic Epidemiology, QIMR Berghofer Medical Research Institute, Brisbane, Australia. Abstract Here we review the motivation for creating the ENIGMA (Enhancing NeuroImaging Genetics through Meta Analysis) Consortium and the genetic analyses undertaken by the consortium so far. We discuss the methodological challenges, findings and future directions of the Genetics Working Group. -
Social Cognitive Neuroscience: a Review of Core Systems
C HAPTER 2 2 SOCIAL COGNITIVE NEUROSCIENCE: A REVIEW OF CORE SYSTEMS Bruce P. Doré, Noam Zerubavel, and Kevin N. Ochsner Descartes famously argued that the mind is both SOCIAL COGNITIVE NEUROSCIENCE everlasting and indivisible (Descartes, 1988). If he APPROACH was right about the first part, he is probably pretty In the past decade, the field of social cognitive neuro- impressed with the advance of human knowledge science (SCN) has attempted to fill this gap, integrat- on the second. Although Descartes’ position on ing the theories and methods of two parent the indivisibility of the mind has been echoed at disciplines: social psychology and cognitive neurosci- times in the history of psychology and neurosci- ence. Stressing the interdependence of brain, mind, ence (Flourens & Meigs, 1846; Lashley, 1929; and social context, SCN seeks to explain psychological Uttal, 2003), the modern field has made steady phenomena at three levels of analysis: the neural level progress in demonstrating that subjective mental of brain systems, the cognitive level of information life can be understood as the product of distinct processing mechanisms, and the social level of the functional systems. Today, largely because of the experiences and actions of social agents (Ochsner & success of cognitive neuroscience models, Lieberman, 2001). In contrast to scientific approaches researchers understand that people’s intellectual that grant near exclusive focus to a single level of anal- faculties emerge from the operation of core ysis (e.g., behaviorism, artificial